Thomsen-Friedenreich antigen activation as a predictor for clinical outcome of pediatric patients with invasive pneumococcal disease

• Main Authors: Yi-Ching Chen (Author), Hsin-Hang Chen (Author), Rajendra-Prasad Janapatla (Author), Anna Dudek (Author), Mei-Hua Hsu (Author), Chyi-Liang Chen (Author), Cheng-Hsun Chiu (Author)
• Format: Book
• Published: Elsevier, 2020-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: The most severe form of pneumococcal disease is invasive pneumococcal disease (IPD), including empyema, sepsis and meningitis. Thomsen-Friedenreich antigen (TA; Galβ1-3GalNAc) activation is known to be a predictor of Streptococcus pneumoniae-associated hemolytic uremic syndrome (Sp-HUS)....